Tracey Lodie
Direktor/Vorstandsmitglied bei Luminary Therapeutics, Inc.
Profil
Tracey Lodie is currently a Director at Luminary Therapeutics, Inc. She was previously the Head-Immune Mediated Research Group at Genzyme Corp.
from 2001 to 2015.
From 2015 to 2017, she was the Senior Vice President-Translational Immunology at Bluerock Therapeutics, Inc. In 2019 to 2021, she was the Chief Scientific Officer at Gamida Cell Ltd.
She also worked as the Vice President-Immunology at Syros Pharmaceuticals, Inc. Dr. Lodie received her undergraduate degree from Fairfield University and her doctorate from Boston University School of Medicine.
Aktive Positionen von Tracey Lodie
| Unternehmen | Position | Beginn |
|---|---|---|
Luminary Therapeutics, Inc.
 Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Tracey Lodie
| Unternehmen | Position | Ende |
|---|---|---|
| GAMIDA CELL LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2021 |
| Bluerock Therapeutics, Inc. | Corporate Officer/Principal | 01.01.2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2015 |
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Tracey Lodie
| Fairfield University | Undergraduate Degree |
| Boston University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN. | Commercial Services |
| Bluerock Therapeutics, Inc. |
